Generics

Filter

Current filters:

None

Popular Filters

1026 to 1050 of 1215 results

Mylan gets tentative FDA approval for generic Epzicom

23-02-2012

US generics major Mylan (Nasdaq: MYL) says that its subsidiary Mylan Laboratories has received tentative…

Anti-viralsEpzicomGenericsGlaxoSmithKlineMylan LaboratoriesNorth AmericaPfizerRegulationViiV Healthcare

Mylan 4th-qtr profits beat expectations, but not sales

21-02-2012

US generic drugs major Mylan (Nasdaq: MYL) yesterday posted financial results for the three months and…

FinancialGenericsMylan Laboratories

Generic drugs key to unlocking savings for Australian economy, says MJA

20-02-2012

A report in the latest issue of the Medical Journal of Australia (MJA), has backed the case for the government…

Asia-PacificGenericsHealthcarePricing

Opportunities for Pharma in narcolepsy

20-02-2012

The narcolepsy therapeutics developmental pipeline is weak, with only six molecules in development, providing…

BioprojectCephalonGenericsMarkets & MarketingNeurologicalNuvigilPharmaceuticalProvigilResearchTeva Pharmaceutical IndustriesUCBXyrem

Pfizer and Hisun flesh-out plans for generics JV in China

19-02-2012

Global drugs behemoth Pfizer (NYSE: PFE) and Zhejiang Hisun Pharmaceutical (SSE Code: 600267), a leading…

Asia-PacificGenericsMergers & AcquisitionsPfizerZhejiang Hisun Pharma

Actavis to debut generic Aricept in EU markets as patents expire

16-02-2012

Icelandic generics firm Actavis yesterday announced the launch of donepezil, a generic copy of Eisai…

ActavisAriceptdonepezilEisaiEuropeGenericsMarkets & MarketingNeurologicalPfizer

Merck & Co sets up marketing JV in Brazil

16-02-2012

Merck & Co (NYSE: MRK) says it has formed a new joint venture with Supera Farma Laboratorios, a Brazilian…

CristaliaEurofarmaGenericsMarkets & MarketingMerck & CoMergers & AcquisitionsPharmaceuticalSouth AmericaSupera Farma

Teva Pharma strong sales growth helped by acquisitions

16-02-2012

Israel-headquartered Teva Pharmaceutical Industries (Nasdaq: TEVA) reported fourth-quarter 2011 results…

CephalonFinancialGenericsPharmaceuticalTeva Pharmaceutical Industries

Impending biologics patent expiries creates huge opportunity for European biosimilars makers

15-02-2012

The biosimilars manufacturing industry is at a nascent stage. However, the impending patent expiries…

BiotechnologyEuropeGenericsMarkets & MarketingPatents

Watson 4th-quarter beats expectations, with 93% rise in net income

15-02-2012

US generic drugmaker Watson Pharmaceuticals (NYSE: WPI) reported a whopping 62% increase to $1.5 billion…

FinancialGenericsWatson Pharmaceuticals

Rush Bill would make most patent settlement deals in USA unlawful

14-02-2012

Last week, US Representative Bobby Rush (Democrat, Illinois) introduced HR 3995, the Protecting Consumer…

GenericsLegalNorth AmericaPharmaceuticalRegulation

Watson confirms patent challenge to Bayer’s Beyaz

13-02-2012

US generic drugmaker Watson Pharmaceuticals (NYSE: WPI) on Friday confirmed that its subsidiary, Watson…

BayerBeyazGenericsNorth AmericaPatentsRegulationReproductiveWatson Pharmaceuticals

Fitch backs FDA planned guidelines, saying they open the door to biosimilars

12-02-2012

Fitch Ratings believes the US Federal Drug and Administration's proposed biosimilar pathway regulations,…

BiotechnologyGenericsHospiraNorth AmericaRegulation

At last, draft guidance on biosimilars pathway from US FDA

10-02-2012

Coming somewhat behind European Union action, the US Food and Drug Administration late yesterday issued…

BiotechnologyGenericsNorth AmericaRegulation

Hospira challenges Cubist patents on Cubicin

10-02-2012

US drugmaker Cubist Pharmaceuticals (Nasdaq: CBST) says that it has received a Paragraph IV Notice Letter…

Antibiotics and Infectious diseasesCubicinCubist PharmaceuticalsGenericsHospiraNorth AmericaPatentsPharmaceuticalResearch

Further protests from activists against EU and India FTA

10-02-2012

As India and the European Union meet today for a Summit in New Delhi to iron out the differences over…

Asia-PacificEuropeGenericsMarkets & MarketingPatentsPharmaceuticalPolitics

New low cost HIV drug to be made by Ugandan company

09-02-2012

Starting as early as next month, Uganda will produce a new low cost and more effective life saving HIV/AIDS…

Anti-viralsGenericsMarkets & MarketingRest of the WorldTenofovir Disoproxil Fumarate

Generics will drive Australia’s PBS saving in 2012, says GMiA

09-02-2012

Australian patients and taxpayers need to make the most of the unprecedented value of medicines coming…

Asia-PacificFinancialGenericsHealthcare

Watson settles with Janssen over Ortho Tri-Cyclen LO

08-02-2012

US generic drugmaker Watson Pharmaceutical (NYSE: WPI) says that its subsidiary, Watson Laboratories,…

GenericsJanssenJohnson & JohnsonLegalNorth AmericaPatentsReproductiveWatson PharmaceuticalsWomen's Health

Sanofi fourth-quarter in line with forecasts; collects damages

08-02-2012

French drug major Sanofi (Euronext: SAN) this morning reported 8.8% growth in fourth-quarter 2011 sales…

ApotexBristol-Myers SquibbFinancialGenericsLegalPatentsPharmaceuticalPlavix

Zydus Cadila third-quarter revenues up 20%

07-02-2012

Indian drugmaker Zydus Cadila posted total revenue of 14.01 billion rupees ($287.7 million) for the third…

FinancialGenericsZydus Cadila

Shanghai Pharma aims to take control of Kony Pharma

07-02-2012

In a regulatory filing with the Hong Kong Stock Exchange yesterday, Shanghai Pharmaceuticals Holding…

Asia-PacificGenericsKony PharmaMergers & AcquisitionsShanghai Pharmaceutical Group

1026 to 1050 of 1215 results

Back to top